Fierce BioTech

DECEMBER 23, 2024

png Listing Introduction Join this webinar to receive expert guidance and learn key considerations for successfully planning pharmacy activities in early phase trials. On Demand Start Date Wed, 02/12/2025 - 15:00 Listing Image DrVince_ListingLogo_250x190.png

Pharmacy 52

Pharmacy Trials Clinical Trials Clinical Development 52

Drug Channels

DECEMBER 13, 2024

This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If As you will see below, CMS projects that outpatient prescription drugs dispensed by retail and mail pharmacies will remain a small share of total U.S. If you sign up before 12 p.m. ET, you can attend the live event.)

Government 98

Government Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

OCTOBER 21, 2024

Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Is my organization haemorrhaging money to stay afloat with the shift to alternative distribution and pharmacy models?

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Marketing Compliance 98

Drug Channels

DECEMBER 10, 2024

This week, Im rerunning some popular posts while I prepare for Fridays Drug Channels Outlook 2025 live video webinar. As you reread the article below, note that some manufacturers have already announced wholesale acquisition cost (WAC) list price declines for 2025. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 52

Pharmacy Pharmaceuticals Drugs Production 52

Fierce BioTech

JANUARY 30, 2025

Self-Serve Hubs: A New Era for HCPs and Medication Access swheeler Thu, 01/30/2025 - 18:54 Thu, 03/27/2025 - 15:00 Resource Type Webinar Dan Cornwell The way healthcare providers (HCPs) navigate medication access is evolving rapidly. On Demand Start Date Thu, 03/27/2025 - 16:00 End Date/Time Thu, 03/27/2025 - 16:00

Pharmacy 52

Pharmacy 52

Drug Channels

SEPTEMBER 10, 2024

I am pleased to announce the full agenda for the inaugural Drug Channels Leadership Forum , which will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. Everyone here at Drug Channels Institute (DCI) is excited to bring this novel event to the drug channels community. I personally assembled the agenda.

Pharmacy 52

Pharmacy Drugs 52

Drug Channels

JUNE 25, 2024

Attendance will be limited, so click here to request an invite for our March 2025 event. Top exceutives from Cencora, Eli Lilly, Optum Rx, and Walgreens will be headlining the inaugural Drug Channels Leadership Forum. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Biosimilars 40

Biosimilars Drugs Pharmacy 40

Agency IQ

JANUARY 4, 2024

Citizen petitions have raised the alarm regarding benzene in recent years, leading to FDA action Valisure, an analytical pharmacy that first alerted the FDA to concerns associated with nitrosamine impurities , recently set its sights on benzene impurities.

FDA 40

FDA Production Laboratories Drugs 40

Agency IQ

AUGUST 16, 2024

Areas of expertise included psychiatry, post-traumatic stress disorder, emergency medicine, pharmacy and medication safety, and statistics. This study is planned to start in late 2024 and conclude in late 2025. Read AgencyIQ analysis of a recent listening session on the topic here. ].

FDA 40

FDA Trials Therapies Regulations 40

FDA Law Blog: Biosimilars

DECEMBER 3, 2023

On November 17th, CMS issued its final guidance on the Discount Program in which it responded to public comments and provided updated guidance for the Discount Program for 2025 and 2026. Manufacturers must sign the agreement by March 1, 2024, to participate in the 2025 plan year. Final Guidance at 2. 1395w-114c(b)(4)(B)(i).

Compliance 105

Compliance Drugs Pharmacy Licensing 105

Alta Sciences

MAY 16, 2025

Consultants CornerReflections from a Study Monitor and Director: A Career in Toxicology, by Bill Brock pmjackson Fri, 05/16/2025 - 18:40 Some might say a reflective piece like this could come across as sounding preachy. This article was published in May 2025. Maybe it is. Image Guest Bloggers_William Brock_Thumbnail_0.png

Laboratories 52

Laboratories Science Pharmaceuticals Pharmaceutical Companies 52

Agency IQ

JUNE 16, 2023

The Agenda also includes several long-term actions expected to take place in 2024 and 2025 – included as part of FDA’s long-term regulatory agenda. The rule, will also, if finalized, address communication with State boards of pharmacy. The anticipated date of publication is June 2023, meaning we should see this regulation imminently.

Regulations 40

Regulations FDA Science Production 40

Agency IQ

FEBRUARY 15, 2024

CDER, CBER Draft 12/29/2025 FDA must issue final guidance no later than 18 months after the close of the public comment period for draft guidance. use of RWE, registries) for capturing post-approval safety and efficacy data for cell and gene therapy products.

FDA 40

FDA Science Biosimilars Clinical Trials 40

Agency IQ

OCTOBER 27, 2023

WUSF / AgencyIQ November 1 Initial deadline for NDSRIs Under a 2023 guidance document, the FDA has recommended that pharmaceutical companies assess Nitrosamine Drug-Related Substance Impurities for their products by November 1, 2023, with confirmatory testing due by August 1, 2025. What ever happened to that thing?

FDA 40

FDA Science Regulations Production 40

National Institute on Drug Abuse: Nora's Blog

JANUARY 6, 2025

8 Currently in the United States, methadone is only available from specialized opioid treatment centers, but studies piloting access through pharmacies have shown promise. Together, we turn our eye to 2025 and the challenges and opportunities ahead.& Risk of dying was similarly low for both groups.

Treatment 111

Treatment Science Drugs Research 111

Drug Channels

NOVEMBER 19, 2024

In Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market , I documented the Inflation Reduction Act’s (IRA) disruption to Medicare Part D prescription drug plans (PDPs). As always, we provide you with a handy table for tallying each chain’s participation and changes from 2024 to 2025. Fein, Ph.D.,

Pharmacy 97

Pharmacy Marketing Drugs 97

Drug Channels

NOVEMBER 13, 2024

For 2025, DCI’s exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that the number of PDPs will drop to a historic low. What’s more, the share of plans with a preferred cost sharing pharmacy network will fall to its lowest rate in more than 10 years. What else should you expect for 2025?

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JANUARY 22, 2025

For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. In fact, nearly all marketed Humira biosimilars are excluded from the larger PBMs 2025 formularies.

Biosimilars 98

Biosimilars Pharmacy Production Drugs 98

Drug Channels

APRIL 9, 2025

It's time for Drug Channels annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within U.S. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. drug channels. What do you think? All rights reserved.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

APRIL 23, 2025

Last week, we examined the growing concentration of specialty drug dispensing revenues among the largest pharmacies. See The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market. Drawing from DCIs new 2025 Economic Report on U.S. Today, we dive deeper. All rights reserved.

Pharmacy 72

Pharmacy Specialty Pharmacies Independent Pharmacies Pharmaceuticals 72

Drug Channels

MARCH 11, 2025

Next week, Drug Channels Institute (DCI) will release our 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. For 2024, DCI estimates that total prescription dispensing revenues at retail, mail, long-term care, and specialty pharmacies reached $683 billion, up 9% from the 2023 figure. to 1:30 p.m.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Marketing Drugs 97

Drug Channels

MAY 30, 2025

Aaron introduces us to GoodRx Community Link , a new offering from GoodRx that allows independent pharmacies to contract directly with GoodRx. To learn about GoodRx Community Link, register for GoodRxs free webinar on either June 3, 2025, or June 4, 2025. Both webinars will be held at 11:00 a.m. Read on for Aarons insights.

Pharmacy 84

Pharmacy Independent Pharmacies Drugs 84

FDA Law Blog: Biosimilars

FEBRUARY 2, 2025

By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drug delivery requirements. The California Board of Pharmacy updated many of the application forms and guidelines in late 2024.

Licensing 59

Licensing Licensing Pharmacy Packaging 59

Drug Channels

MARCH 31, 2025

Threes still company in the world of pharmacy benefit managers. For a deeper dive into the state of the industry, join me this Friday, April 4, 2025, for our live video webinar: PBM Industry Update: Trends, Challenges, and Whats Ahead. P.S. Special launch pricing on our new 2025 Economic Report on U.S.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

MAY 20, 2025

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: Whats Next for Retail Pharmacy: Data, Debate, and Disruption This event will be broadcast live on: Friday, June 20, 2025 12:00 p.m. It is part of The Drug Channels 2025 Video Webinar Series.

Pharmacy 75

Pharmacy Pharmaceuticals Marketing Drugs 75

Drug Channels

MARCH 18, 2025

I am pleased to announce that Drug Channels Institutes new 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers is now available for purchase and immediate download. Pharmacies and Pharmacy Benefit Managers. 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Pharmacy 52

Pharmacy Specialty Pharmacies Licensing Licensing 52

Drug Channels

MAY 6, 2025

Below, we use these new disclosures to illustrate the 340B programs hidden prescription economics for 340B contract specialty pharmacies operated by CVS Health and Walgreens Boots Alliance. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. What do you think?

Pharmacy 86

Pharmacy Specialty Pharmacies Drugs Hospitals 86

Drug Channels

FEBRUARY 18, 2025

Small pharmacies have ghosted Medicare Part Ds preferred networksno farewell party, no breakup text, just a quiet exit. A few months ago , DCI highlighted how the largest pharmacy chains are participating as preferred cost sharing pharmacies in the 2025 stand-alone prescription drug plan (PDP) networks. Abracadabra!

Pharmacy 52

Pharmacy Independent Pharmacies Marketing Drugs 52

Drug Channels

MAY 8, 2025

Mike shares key takeaways on patient access and affordability from CoverMyMeds 2025 Medication Access Report. He focuses on the systemic fragmentation that exists across payers, providers, and pharmacies. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Mikes insights.

Pharmacy 59

Pharmacy Treatment Drugs 59

Drug Channels

FEBRUARY 7, 2025

Todays guest post comes from Richard Faris, Chief Strategy & Growth Officer at PANTHERx Rare Pharmacy. He explains the key considerations for choosing a specialty pharmacy network design, selecting the right pharmacy partners, and establishing patient services HUBs. Read on for Richards insights. All rights reserved.

Specialty Pharmacies 64

Specialty Pharmacies Pharmacy Disease Treatment 64

Drug Channels

FEBRUARY 25, 2025

In this issue: How Part D plan sponsors responded to pharmacy DIR changes Troubling new data on copay accumulators in marketplace plans DCIs latest vertical integration visualization How the IRA will hurt physician practices Plus, cartoon cats explain the 340B Drug Pricing Program. Winteror at least Februaryis almost over.

Pharmacy 59

Pharmacy Drugs 59

Drug Channels

APRIL 1, 2025

Click here to see the original post from January 2025. For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. What do you think? All rights reserved.

Biosimilars 52

Biosimilars Pharmacy Production Drugs 52

FDA Law Blog: Biosimilars

FEBRUARY 18, 2025

Hull A recent DEA decision revoking the registration of a Louisiana pharmacy sheds light on the Agencys approach to crediting one experts testimony over that of another expert during an administrative hearing. In Neumanns Pharmacy, LLC , 90 Fed. By Andrew J.

Testimonials 69

Testimonials Pharmacy Government Drugs 69

Drug Channels

MAY 28, 2025

Whats Next for Retail Pharmacy: Data, Debate, and Disruption. Dont miss DCIs first webinar of the year on June 20, 2025 (12:001:30 p.m. Well unpack the good, the bad, and the ugly of the pharmacy industryand explore what it means for you. ET), featuring Dr. Adam J. Fein and Antonio Ciaccia. All rights reserved.

Pharmacy 52

Pharmacy Drugs International 52

Drug Channels

JANUARY 14, 2025

During my recent Drug Channels Outlook 2025 video webinar, I tackled a wide range of crucial topicsincluding the controversial 340B Drug Pricing Program. As I explain in this video excerpt, we may finally see reform of this rapidly expanding program.

Pharmacy 52

Pharmacy Hospitals Marketing Drugs 52

Drug Channels

DECEMBER 11, 2024

This week, Im rerunning some popular posts while I prepare for Fridays Drug Channels Outlook 2025 live video webinar. In the video excerpt below, I walk through a brief history of 340B contract pharmacies. I conclude with a follow the dollar example of 340B prescription economics with contract pharmacies.

Pharmacy 52

Pharmacy Hospitals Marketing Drugs 52

Drug Channels

MARCH 21, 2025

Greg discusses some of the challenges manufacturers face with product commercialization, patient access and adherence, and negotiating partnerships with pharmacy benefit managers (PBMs). Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Greg's insights.

Pharmacy 98

Pharmacy Production Drugs 98